Erratum: Effect of apocynin treatment on renal expression of COX-2, NOS1, and renin in Wistar-Kyoto and spontaneously hypertensive rats (American Journal of Physiology-Regulatory Integrative and Comparative Physiology (March 2006) 290 (R694-R700) DOI: 10.1152/ajpregu.00219.2005);Effect of apocynin treatment on renal expression of COX-2, NOS1, and renin in Wistar-Kyoto and spontaneously hypertensive rats

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 290, Issue 3, 2006, Pages

  Paliege, A ^a,b   Parsumathy, A ^b   Mizel, D ^b   Yang, T ^c   Schnermann, J ^b   Bachmann, S ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^c UNIVERSITY OF UTAH   (United States)

Author keywords

Reactive oxygen species; Tubulovascular signaling

Indexed keywords

APOCYNIN; CYCLOOXYGENASE 2; ISOPROSTANE; MESSENGER RNA; NEURONAL NITRIC OXIDE SYNTHASE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; RENIN; ACETOPHENONE DERIVATIVE; CYCLOOXYGENASE 1; MEMBRANE PROTEIN; NITRIC OXIDE SYNTHASE; NOS1 PROTEIN, RAT; PTGS1 PROTEIN, RAT; PTGS2 PROTEIN, RAT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; GLOMERULUS FILTRATION RATE; HISTOCHEMISTRY; IMMUNOREACTIVITY; JUXTAGLOMERULAR APPARATUS; KIDNEY FUNCTION; NONHUMAN; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RAT STRAIN; SPONTANEOUSLY HYPERTENSIVE RAT; SYSTOLIC BLOOD PRESSURE; ANIMAL; BLOOD PRESSURE; GENE EXPRESSION REGULATION; HYPERTENSION; KIDNEY; METABOLISM; TISSUE DISTRIBUTION; TREATMENT OUTCOME; WISTAR KYOTO RAT;

ACETOPHENONES; ANIMALS; BLOOD PRESSURE; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; GENE EXPRESSION REGULATION; HYPERTENSION; KIDNEY; MEMBRANE PROTEINS; NITRIC OXIDE SYNTHASE; RATS; RATS, INBRED SHR; RATS, INBRED WKY; REACTIVE OXYGEN SPECIES; RENIN; TISSUE DISTRIBUTION; TREATMENT OUTCOME;

EID: 33645402582     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.00358.2006     Document Type: Erratum

References (37)

1. Bachmann S, Bosse HM, and Mundel P. Topography of nitric oxide synthesis by localizing constitutive NO synthases in mammalian kidney. Am J Physiol Renal Fluid Electrolyte Physiol 268: F885-F898, 1995.
2. Bachmann S and Mundel P. Nitric oxide in the kidney: synthesis, localization, and function. Am J Kidney Dis 24: 112-129, 1994.
3. Bachmann S and Ramasubbu K. Immunohistochemical colocalization of the alpha-subunit of neutrophil NADPH oxidase and ecto-5′-nucleotidase in kidney and liver. Kidney Int 51: 479-482, 1997.
4. Bagby SP, McDonald WJ, and Mass RD. Serial renin-angiotensin studies in spontaneously hypertensive and Wistar-Kyoto normotensive rats. Transition from normal- to high-renin status during the established phase of spontaneous hypertension. Hypertension 1: 347-354, 1979.
5. Beierwaltes WH. Macula densa stimulation of renin is reversed by selective inhibition of neuronal nitric oxide synthase. Am J Physiol Regul Integr Comp Physiol 272: R1359-R1364, 1997.
6. Beswick RA, Dorrance AM, Leite R, and Webb RC. NADH/NADPH oxidase and enhanced superoxide production in the mineralocorticoid hypertensive rat. Hypertension 38: 1107-1111, 2001.
7. Bosse HM and Bachmann S. Immunohistochemically detected protein nitration indicates sites of renal nitric oxide release in Goldblatt hypertension. Hypertension 30: 948-952, 1997.
8. Bosse HM, Bohm R, Resch S, and Bachmann S. Parallel regulation of constitutive NO synthase and renin at JGA of rat kidney under various stimuli. Am J Physiol Renal Fluid Electrolyte Physiol 269: F793-F805, 1995.
9. Câmpean V, Theilig F, Paliege A, Breyer M, and Bachmann S. Key enzymes for renal prostaglandin synthesis: site-specific expression in rodent kidney (rat, mouse). Am J Physiol Renal Physiol 285: F19-F32, 2003.
10. Chabrashvili T, Tojo A, Onozato ML, Kitiyakara C, Quinn MT, Fujita T, Welch WJ, and Wilcox CS. Expression and cellular localization of classic NADPH oxidase subunits in the spontaneously hypertensive rat kidney. Hypertension 39: 269-274, 2002.
11. Engels F, Renirie BF, Hart BA, Labadie RP, and Nijkamp FP. Effects of apocynin, a drug isolated from the roots of Picrorhiza kurroa, on arachidonic acid metabolism. FEBS Lett 305: 254-256, 1992.
12. Eyries M, Collins T, and Khachigian LM. Modulation of growth factor gene expression in vascular cells by oxidative stress. Endothelium 11: 133-139, 2004.
13. Feld LG, Van Liew JB, Galaske RG, and Boylan JW. Selectivity of renal injury and proteinuria in the spontaneously hypertensive rat. Kidney Int 12: 332-343, 1977.
14. Herlitz H, Lundin S, Henning M, Aurell M, Karlberg BE, and Berglund G. Hormonal pattern during development of hypertension in spontaneously hypertensive rats (SHR). Clin Exp Hypertens A 4: 915-935, 1982.
15. Kerr S, Brosnan MJ, McIntyre M, Reid JL, Dominiczak AF, and Hamilton CA. Superoxide anion production is increased in a model of genetic hypertension: role of the endothelium. Hypertension 33: 1353-1358, 1999.
16. Limas CJ and Limas C. Prostaglandin metabolism in the kidneys of spontaneously hypertensive rats. Am J Physiol Heart Circ Physiol 233: H87-H92, 1977.
17. Lykkegard S and Poulsen K. Ultramicroassay for plasma renin concentration in the rat using the antibody-trapping technique. Anal Biochem 75: 250-259, 1976.
18. Morrow JD and Roberts LJ. The isoprostanes: unique bioactive products of lipid peroxidation. Prog Lipid Res 36: 1-21, 1997.
19. Morton JJ, Beattie EC, Griffin SA, MacPherson F, Lyall F, and Russo D. Vascular hypertrophy, renin and blood pressure in the young spontaneously hypertensive rat. Clin Sci (Lond) 79: 523-530, 1990.
20. Nishikawa Y, Tatsumi K, Matsuura T, Yamamoto A, Nadamoto T, and Urabe K. Effects of vitamin C on high blood pressure induced by salt in spontaneously hypertensive rats. J Nutr Sci Vitaminol (Tokyo) 49: 301-309, 2003.
21. Peti-Peterdi J, Komlosi P, Fuson AL, Guan Y, Schneider A, Qi Z, Redha R, Rosivall L, Breyer MD, and Bell PD. Luminal NaCl delivery regulates basolateral PGE2 release from macula densa cells. J Clin Invest 112: 76-82, 2003.
22. Racasan S, Braam B, Koomans HA, and Joles JA. Programming blood pressure in SHR by shifting the perinatal balance of NO and reactive oxygen species towards NO: the inverted Barker phenomenon. Am J Physiol Renal Physiol 287: F626-F636, 2004.
23. Schnackenberg CG and Wilcox CS. Two-week administration of tempol attenuates both hypertension and renal excretion of 8-Iso prostaglandin f2alpha. Hypertension 33: 424-428, 1999.
24. Sen S, Smeby RR, and Bumpus FM. Renin in rats with spontaneous hypertension. Circ Res 31: 876-880, 1972.
25. Shiono K and Sokabe H. Renin-angiotensin system in spontaneously hypertensive rats. Am J Physiol 231: 1295-1299, 1976.
26. Silvagno F, Xia H, and Bredt DS. Neuronal nitric-oxide synthase-mu, an alternatively spliced isoform expressed in differentiated skeletal muscle. J Biol Chem 271: 11204-11208, 1996.
27. Singh I, Grams M, Wang WH, Yang T, Killen P, Smart A, Schnermann J, and Briggs JP. Coordinate regulation of renal expression of nitric oxide synthase, renin, and angiotensinogen mRNA by dietary salt. Am J Physiol Renal Fluid Electrolyte Physiol 270: F1027-F1037, 1996.
28. Theilig F, Bostanjoglo M, Pavenstadt H, Grupp C, Holland G, Slosarek I, Gressner AM, Russwurm M, Koesling D, and Bachmann S. Cellular distribution and function of soluble guanylyl cyclase in rat kidney and liver. J Am Soc Nephrol 12: 2209-2220, 2001.
29. Thorup C and Persson AE. Inhibition of locally produced nitric oxide resets tubuloglomerular feedback mechanism. Am J Physiol Renal Fluid Electrolyte Physiol 267: F606-F611, 1994.
30. Vallon V and Thomson S. Inhibition of local nitric oxide synthase increases homeostatic efficiency of tubuloglomerular feedback. Am J Physiol Renal Fluid Electrolyte Physiol 269: F892-F899, 1995.
31. Vaziri ND, Ni Z, Oveisi F, and Trnavsky-Hobbs DL. Effect of antioxidant therapy on blood pressure and NO synthase expression in hypertensive rats. Hypertension 36: 957-964, 2000.
32. Weichert W, Paliege A, Provoost AP, and Bachmann S. Upregulation of juxtaglomerular NOS1 and COX-2 precedes glomerulosclerosis in fawn-hooded hypertensive rats. Am J Physiol Renal Physiol 280: F706-F714, 2001.
33. Welch WJ, Tojo A, and Wilcox CS. Roles of NO and oxygen radicals in tubuloglomerular feedback in SHR. Am J Physiol Renal Physiol 278: F769-F776, 2000.
34. Wilcox CS, Welch WJ, Murad F, Gross SS, Taylor G, Levi R, and Schmidt HH. Nitric oxide synthase in macula densa regulates glomerular capillary pressure. Proc Natl Acad Sci USA 89: 11993-11997, 1992.
35. Xu H, Fink GD, and Galligan JJ. Nitric oxide-independent effects of tempol on sympathetic nerve activity and blood pressure in DOCA-salt rats. Am J Physiol Heart Circ Physiol 283: H885-H892, 2002.
36. Zanzinger J and Czachurski J. Chronic oxidative stress in the RVLM modulates sympathetic control of circulation in pigs. Pflügers Arch 439: 489-494, 2000.
37. Zhan CD, Sindhu RK, and Vaziri ND. Up-regulation of kidney NAD(P)H oxidase and calcineurin in SHR: reversal by lifelong antioxidant supplementation. Kidney Int 65: 219-227, 2004.